Providers

Medical Policy Upcoming Updates

Notification Date: September 21, 2022

Below are the policies that are new or have been reviewed, along with the determination and summary of any changes.

Policy Title	Status	Effective Date	Determination	Summary of Changes
Electric Cell-Signaling Treatment (e.g., neoGEN® System, Sanexas Intl.)	New	11/21/2022	Investigative and therefore not covered	N/A
Genetic Testing: Non-Invasive Prenatal Screening (NIPS)	New	11/21/2022	Medically necessary for some indications; investigational for all other indications.	Replaces former Medica coverage policy, Maternal Plasma Tests for Detection of Cell-free Fetal DNA for Analysis of Chromosomal Aneuploidies*. Criteria for maternal serum screening (e.g., free or total beta-HCG and PAPP-A) has been added.
Genetic Testing: Preimplantation Genetic Testing	New	11/21/2022	Medically necessary for some indications; investigational for all other indications.	N/A
Genetic Testing: Prenatal And Preconception Carrier Screening	New	11/21/2022	Medically necessary for some indications; investigational for all other indications.	N/A
Genetic Testing: Prenatal Diagnosis (Via Amniocentesis, Cvs, Or Pubs) And Pregnancy Loss	New	11/21/2022	Medically necessary for some indications; investigational for all other indications.	N/A